Skip to menu Skip to content Skip to footer

2023

Conference Publication

275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival

Zhou, C., Tan, S. X., Kao, Y., Claeson, M., Brown, S., Lambie, D., Whiteman, D., Soyer, H., Stark, M., Nguyen, Q. and Khosrotehrani, K. (2023). 275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.279

275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival

2023

Conference Publication

Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients

Cox, Charlotte, Lee, Ruby, Liyanage, Upekha, Brown, Susan, Isbel, Nicole, Chambers, Daniel, Griffin, Anthony, Campbell, Scott, Hopkins, Peter, Schaider, Helmut, Soyer, Peter and Khosrotehrani, Kiarash (2023). Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients. HOBOKEN: WILEY.

Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients

2023

Conference Publication

Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial

Cox, C., Fry, K., Sivakumaran, Y., Spelman, L. and Khosrotehrani, K. (2023). Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial. 1st International Societies for Investigative Dermatology Meeting Abstract Supplement, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1530

Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial

2023

Conference Publication

A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancy

Mahon, Clare and Khosrotehrani, Kiarash (2023). A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancy. HOBOKEN: WILEY.

A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancy

2023

Conference Publication

1439 Development of a complex skin organ in human induced pluripotent stem cell-derived organoids

Shafiee, A., Sun, J., Ahmed, I., Brown, J. and Khosrotehrani, K. (2023). 1439 Development of a complex skin organ in human induced pluripotent stem cell-derived organoids. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1455

1439 Development of a complex skin organ in human induced pluripotent stem cell-derived organoids

2023

Conference Publication

PDGFRA-expressing endovascular progenitors contribute to differentiated endothelium of aorta and wounds

Styke, C., Kaur, S., Sim, S., Zhao, J., Shafiee, A., Zhou, C., Wong, H. and Khosrotehrani, K. (2023). PDGFRA-expressing endovascular progenitors contribute to differentiated endothelium of aorta and wounds. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1476

PDGFRA-expressing endovascular progenitors contribute to differentiated endothelium of aorta and wounds

2023

Conference Publication

The impact of immune checkpoint inhibitors on actinic keratosis

Cox, Charlotte, Brown, Susan, Ladwa, Rahul and Khosrotehrani, Kiarash (2023). The impact of immune checkpoint inhibitors on actinic keratosis. HOBOKEN: WILEY.

The impact of immune checkpoint inhibitors on actinic keratosis

2023

Conference Publication

Automated assessment of tumor infiltrating lymphocytes informs mortality in thin melanoma

Tan, S. X., Aung, T. Nwe, Claeson, M., Zhou, C., Brown, S., Acs, B., Lambie, D., Baade, P., Pandeya, N., Soyer, H., Smithers, B., Whiteman, D., Rimm, D. and Khosrotehrani, K. (2023). Automated assessment of tumor infiltrating lymphocytes informs mortality in thin melanoma. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 12 - 13 May 2023. Oxford, United Kingdom: Elsevier.

Automated assessment of tumor infiltrating lymphocytes informs mortality in thin melanoma

2023

Conference Publication

Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis

Hashemi, G., Le Bourhis, L. Sormani, Dight, J., Zhou, C., Roy, E. and Khosrotehrani, K. (2023). Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10-13 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.jid.2023.03.1288

Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis

2023

Conference Publication

Epidermal somatic mutation is correlated with keratinocyte cancer burden

Lee, Ruby, Wong, Ho Yi, Brown, Susan, Roy, Edwige, Soyer, Peter and Khosrotehrani, Kiarash (2023). Epidermal somatic mutation is correlated with keratinocyte cancer burden. HOBOKEN: WILEY.

Epidermal somatic mutation is correlated with keratinocyte cancer burden

2023

Conference Publication

1511 Macrophages regulate endothelial progenitors’ quiescence and self-renewal during homeostasis and cutaneous wound healing via paracrine signaling

Sim, S., Kaur, S., Styke, C., Millard, S., Blumenthal, A., Pettit, A. and Khosrotehrani, K. (2023). 1511 Macrophages regulate endothelial progenitors’ quiescence and self-renewal during homeostasis and cutaneous wound healing via paracrine signaling. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1528

1511 Macrophages regulate endothelial progenitors’ quiescence and self-renewal during homeostasis and cutaneous wound healing via paracrine signaling

2023

Conference Publication

Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trial

Cox, Charlotte, Fry, Kirsty, Sivakumaran, Yogeesan, Spelman, Lynda and Khosrotehrani, Kiarash (2023). Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trial. HOBOKEN: WILEY.

Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trial

2023

Conference Publication

Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy

Wong, H., Lee, R., Chong, S., Kapadia, S., Murigneux, V., Freeman, M., Soyer, H., Roy, E. and Khosrotehrani, K. (2023). Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 12 - 13 May 2023. Oxford, United Kingdom: Elsevier.

Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy

2023

Conference Publication

Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort study

Lee, Ruby, Tseng, Anne, Liyanage, Upekha, Brown, Susan and Khosrotehrani, Kiarash (2023). Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort study. HOBOKEN: WILEY.

Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort study

2023

Journal Article

Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trial

Cox, C., Fry, K., Sivakumaran, Y., Spelman, L. and Khosrotehrani, K. (2023). Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trial. Journal of the European Academy of Dermatology and Venereology, 143 (5), S259-e975. doi: 10.1111/jdv.19041

Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trial

2023

Journal Article

Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?

Bromfield, Jacoba Isobella, Hugenholtz, Philip, Frazer, Ian Hector, Khosrotehrani, Kiarash and Chandra, Janin (2023). Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?. Frontiers in Oncology, 13 1091379, 1091379. doi: 10.3389/fonc.2023.1091379

Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?

2023

Journal Article

Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal study

Tedman, Alexander James, Liyanage, Upekha E., Chong, Sharene, Rowe, Casey, von Schuckmann, Lena A., Malt, Maryrose, Green, Adele C., Smithers, B. Mark and Khosrotehrani, Kiarash (2023). Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal study. Australasian Journal of Dermatology, 64 (1), e34-e40. doi: 10.1111/ajd.13974

Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal study

2023

Journal Article

Tribute to reviewers

Khosrotehrani, Kiarash and Schaider, Helmut (2023). Tribute to reviewers. Australasian Journal of Dermatology, 64 (1), 162-166. doi: 10.1111/ajd.13990

Tribute to reviewers

2023

Journal Article

Risk factors associated with first and second primary melanomas in a high-incidence population

Olsen, Catherine M., Pandeya, Nirmala, Dusingize, Jean Claude, Neale, Rachel E., MacGregor, Stuart, Law, Matthew H., Whiteman, David C., for the QSkin Study, Hayward, Nicholas K., Khosrotehrani, Kiarash and Gordon, Louisa G. (2023). Risk factors associated with first and second primary melanomas in a high-incidence population. JAMA Dermatology, 159 (1), 37-46. doi: 10.1001/jamadermatol.2022.4975

Risk factors associated with first and second primary melanomas in a high-incidence population

2022

Conference Publication

Epidermal ablation reduces keratinocyte cancer burden by lowering skin mutation load

Wong, H., Lee, R., Roy, E., Kapadia, S., Murigneux, V., Chong, S., Freeman, M. and Khosrotehrani, K. (2022). Epidermal ablation reduces keratinocyte cancer burden by lowering skin mutation load. 51st Annual ESDR Meeting, Amsterdam, Netherlands, 28 September-1 October 2022. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2022.09.449

Epidermal ablation reduces keratinocyte cancer burden by lowering skin mutation load